MicroRNAs as potential therapeutics to enhance chemosensitivity in advanced prostate cancer

Docetaxel and cabazitaxel are taxane chemotherapy treatments for metastatic castration-resistant prostate cancer (CRPC). However, therapeutic resistance remains a major issue. MicroRNAs are short non-coding RNAs that can silence multiple genes, regulating several signalling pathways simultaneously....

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Hui-Ming, Nikolic, Iva, Yang, Jessica, Castillo, Lesley, Deng, Niantao, Chan, Chia-Ling, Yeung, Nicole K., Dodson, Eoin, Elsworth, Benjamin, Spielman, Calan, Lee, Brian Y., Boyer, Zoe, Simpson, Kaylene J., Daly, Roger J., Horvath, Lisa G., Swarbrick, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5959911/
https://www.ncbi.nlm.nih.gov/pubmed/29777112
http://dx.doi.org/10.1038/s41598-018-26050-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5959911/
https://www.ncbi.nlm.nih.gov/pubmed/29777112
http://dx.doi.org/10.1038/s41598-018-26050-y

Ejemplares similares